After being delayed due to Covid-19 related restrictions, the 12th International RSV Symposium (RSV2022) finally took place in Belfast, Northern Ireland on 29 September – 2 October 2022. This global conference is organised by the International Respiratory Syncytial Virus Society (IRSVS) and is addressed to RSV researchers in academia and industry, hosting scientists, students, non-profits, regulators, sponsors and industry.
It was the biggest symposium to date, and there were presentations on a broad range of topics from basic science related advances to big-data related RSV projects, although as to be expected a big focus on therapeutics & vaccines.
In addition, there was a large poster exhibition; where one of the Early Career Researchers in PROMISE, Zak Sheik, from the University of Edinburgh, presented a poster on work relating to deliverable 1.1, specifically developing and validating simplified versions of the ReSVinet score, a novel clinical score for RSV severity.
“I particularly enjoyed Prof. Adnan Custovic’s keynote talk in the penultimate session on using ML-methods to explore the relationship between asthma and RSV bronchiolitis.“
Zak Sheik, medical student at the University of Edinburgh
PROMISE partners from other organisations such as the National Institute for Public Health and the Environment (RIVM) and Turku University Hospital (TUCH) also attended the meeting. It was an excellent opportunity to share their work, connect with stakeholders and maximise communications about the PROMISE project. We look forward to more opportunities to present the PROMISE results!
This was an excellent opportunity for PROMISE partners to share their work, connect with stakeholders and maximise communications about the project.
